Ruolan Han
Impact in
- Genetics top 2%
- Glioma Diagnosis and Treatment
-
- Cancer-related cognitive impairment studies
- Brain Metastases and Treatment
- Sarcoma Diagnosis and Treatment
Papers in
-
- Cancer-related gene regulation 2
-
- Sarcoma Diagnosis and Treatment 3
- Cancer-related cognitive impairment studies 3
- Co-authors
- Mark Noble (4 shared papers)Yin Yang (4 shared papers)Jöerg Dietrich (3 shared papers)Margot Mayer‐Pröschel (2 shared papers)Anne E. Luebke (1 shared paper)Margot Mayer-Pröschel (1 shared paper)Jeffrey L. Larson (2 shared papers)Brian Dawson (1 shared paper)
- Journals
- Cancer Research (4 papers)Journal of Biology (2 papers)Journal of Neuroscience (1 paper)Free Radical Biology and Medicine (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesSlovakiaSpain
In The Last Decade
Ruolan Han
18 papers receiving 840 citations
Ruolan Han's Hit Papers
Peers
Comparison fields: 5 of 87
- Genetics 371
- Pulmonary and Respiratory Medicine 535
- Developmental Neuroscience 67
- Oncology 124
- Biological Psychiatry 11
Countries citing papers authored by Ruolan Han
This map shows the geographic impact of Ruolan Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruolan Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruolan Han more than expected).
Fields of papers citing papers by Ruolan Han
This network shows the impact of papers produced by Ruolan Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruolan Han. The network helps show where Ruolan Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruolan Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo Hit paper breakdown → | 2006 | 426 |
| 2 | 2008 | 257 | |
| 3 | 2019 | 86 | |
| 4 | 2021 | 22 | |
| 5 | 2023 | 16 | |
| 6 | 2013 | 15 | |
| 7 | 2022 | 13 | |
| 8 | 2014 | 13 | |
| 9 | 2023 | 9 | |
| 10 | 2022 | 5 | |
| 11 | 2022 | 5 | |
| 12 | 2022 | 3 | |
| 13 | 2018 | 2 | |
| 14 | 2018 | 1 | |
| 15 | 2023 | 1 | |
| 16 | 2019 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2022 | 1 |
About Ruolan Han
Ruolan Han is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Biotechnology and Immunology, having authored 18 papers that have together received 877 indexed citations. Recurring topics across this work include Cancer Research and Treatments (4 papers), Sarcoma Diagnosis and Treatment (3 papers), Cancer-related cognitive impairment studies (3 papers), interferon and immune responses (3 papers), Glioma Diagnosis and Treatment (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Cancer-related gene regulation (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Genetics (371 citations), Pulmonary and Respiratory Medicine (535 citations), Developmental Neuroscience (67 citations), Oncology (124 citations) and Biological Psychiatry (11 citations). Ruolan Han has collaborated with scholars based in United States, Slovakia and Spain. Frequent co-authors include Mark Noble, Yin Yang, Jöerg Dietrich, Margot Mayer‐Pröschel, Anne E. Luebke, Margot Mayer-Pröschel, Jeffrey L. Larson, Brian Dawson, Cristian Coarfa and Jason T. Yustein. Their work appears in journals such as Cancer Research, Journal of Biology, Journal of Neuroscience, Free Radical Biology and Medicine and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.